Fair and cost-conscious allocation of omalizumab, a groundbreaking food allergy therapy. Buckey TM, Sun D, Spergel JM. Ann Allergy Asthma Immunol 2024;133:18-19.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Buckey TM, Sun D, Spergel JM. Fair and cost-conscious allocation of omalizumab, a groundbreaking food allergy therapy. Ann Allergy Asthma Immunol 2024;133:18-19.
PMID: 38960561